Latest posts

A Discussion About the Challenges and Opportunities Ahead In a panel moderated by Dr. John Waddell (Boehringer Ingelheim Vetmedica, Senior Professional Services Veterinarian), Dr. Dave Bomgaars (President at RC Family Farms and Orange City Veterinary Clinic), Dr. Jim Lowe (Associate Professor and Director of the i-Learning Center, College of Veterinary Medicine at the University of Illinois), and Bill Davis (Boehringer Ingelheim Director of Government Affairs) discuss the issues of critical importance today with the pork industry and thoughts on the future [video].

Tech Talk – IAV-S Control: Reminders of What Made Whole Herd Approach (WHA) a Success Dr. Christa Goodell, Boehringer Ingelheim, shares information on IAV-S control and reminds us of what made the Whole Herd Approach a success [video].

Updates on Government Regulations and Future Elections Bill Davis, Boehringer Ingelheim Director of Government Affairs, reviews the 2018 election activity, impacts on regulation and policy, and what it might mean for the 2020 election [video].

Tech Talk – Economic & Production Benefit of 2 PRRS MLV Doses Compared to a Single Dose Vaccination Program in Growing Pigs Dr. Cesar A.A. Moura, Veterinary Diagnostic and Production Animal Medicine, Iowa State University, shares research and analysis on the production and economic benefit of 2 PRRS MLV doses compared to a single dose vaccination program on growing pigs. [video].

Tech Talk – Fact vs. Fiction – PCV3 Unraveled Dr. Eduardo Fano, Boehringer Ingelheim, updates us on PCV3, and highlights facts versus myths. Some key observations: 1) PCV3 is widespread in the U.S. and co-infections with PCV2 and PRRSV are commonly found in PCV3 samples, 2) Clinical association: PDNS, Multi-systemic, reproductive failure, PRDC and tremors, and 3) Reproductive Failure has been the most consistent clinical association [video].